eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent

  • Nevan Krogan

Press/Media

Period22 Jul 2021

Media coverage

13

Media coverage